Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 EUR | +6.06% |
|
-1.06% | -35.29% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-35.29% | 1.6B | - | ||
+25.79% | 89.17B | C+ | ||
-23.21% | 75.87B | B- | ||
+2.32% | 27.41B | C+ | ||
-10.58% | 17.52B | B | ||
-0.32% | 17.04B | A- | ||
+0.52% | 15.36B | A- | ||
+77.83% | 13.67B | C- | ||
+79.56% | 13.18B | C+ | ||
-25.61% | 12.83B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 1833 Stock
- 1XZ Stock
- Ratings Ping An Healthcare and Technology Company Limited